Roche confirms over 200 job cuts at Irish facility

pharmafile | May 18, 2016 | News story | Manufacturing and Production Roche, clare, clarecastle, closure, irish site, job cuts, job losses 

Swiss pharmaceutical company Roche (VTX: ROG) has confirmed that 240 jobs are to go at their Irish site in Clare, which is set to close by 2019.

The company had originally announced its intention to leave the site late last year, but indicated that it would attempt to transfer the plant to a global pharma services company. These negotiations, however, were unsuccessful.

The facility in Clarecastle has been operational since 1974, and is Roche’s only operational presence in Ireland.

A company statement sad that all production at the site will “cease in a phased approach currently estimated to be completed between 2018 and 2019 when Roche will exit the site.”

The company will now enter into consultation with staff and their representatives going forward. The closure of the Irish site comes as Roche looks to focus its attention on a “new generation of specialised medicines”.

Sean Murray

Related Content

Roche’s Vabysmo approved by FDA for retinal vein occlusion treatment

Roche has announced that the US Food and Drug Administration (FDA) has approved Vabysmo (farcimab) …

Roche announces acquisition of Telavant

Roche has announced that it has entered into a definitive agreement to acquire Telavant Holdings, …

EC approves Roche’s Evrysdi for babies under two months with SMA

Roche has announced that the European Commission (EC) has approved the extension of Evrysdi’s marketing …

Latest content